πŸ‡ΊπŸ‡Έ FDA
Patent

US 11957683

Bicyclic compounds

granted A61KA61K31/513A61K31/519

Quick answer

US patent 11957683 (Bicyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K31/513, A61K31/519, A61K31/522, A61K31/675